CMS, FDA launch RAPID pathway to fast-track Medicare coverage for breakthrough devices

CMS and the FDA jointly announced the RAPID Coverage Pathway, a new voluntary program designed to accelerate Medicare coverage for FDA-designated breakthrough devices. The program aims to align FDA approval and CMS coverage decisions, potentially reducing the typical multi-year lag for new technology reimbursement. For practices that adopt new devices, this could mean fewer coverage gaps and denials for patients. The pathway is now accepting applications; device manufacturers will drive participation. No immediate action is required from providers, but this signals a shift toward faster reimbursement cycles for innovative care.